Core Insights - Piper Sandler Companies has appointed Jason Arnold as a managing director in its healthcare investment banking group, initially based in London, to serve clients globally [1][2]. Company Overview - Piper Sandler is a leading investment bank focused on helping clients realize partnership opportunities, offering securities brokerage and investment banking services in various regions including the U.S., U.K., EU, and Abu Dhabi [5]. Personnel Background - Jason Arnold brings 16 years of experience from William Blair's healthcare investment banking group and has a background from Ernst & Young. He holds both a bachelor's and a master's degree from the University of Colorado, Boulder [4]. Strategic Focus - Arnold will advise life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships, and capital raising transactions, enhancing the firm's capabilities in delivering strategic advice [1][2][3].

格隆汇2月2日｜William Blair分析师Alexandra Symeonidi在报告中表示，由于白银价格在上周五随金价 大跌而重挫超过30%，预计今年该贵金属将经历剧烈的价格波动。分析师指出，白银市场持续面临流动 性挑战，而市场供需平衡数据预示今年将出现供应短缺。此外，投机头寸已有所下降，表明投机因素不 太可能是此前白银上涨的驱动力。然而，Symeonidi补充称，占总需求约60%的工业需求目前表现疲 软，且即便近期大跌，白银年内至今的涨幅依然存在。因此，她认为白银以及更广泛的金属市场可能将 持续维持高波动水平。 ...

Core Insights - Visa is launching advisory services to assist clients in utilizing stablecoins, responding to increased demand in the payments ecosystem [2][3] - The company has begun offering these services as of last month, despite anticipating limited consumer use cases for stablecoins in the U.S. [2] - Visa's stablecoin settlement services for corporate clients have an annualized run rate of approximately $4.6 billion globally [4] Group 1: Market Demand and Strategy - There is growing interest from both stablecoin-native and traditional clients in developing stablecoin strategies, indicating a shift in the payments landscape [3] - Visa aims to create a secure and seamless interoperable layer between stablecoins and traditional fiat payments, targeting a significant $20 trillion cross-border market opportunity [5] Group 2: Competitive Landscape - Analysts suggest that stablecoins could pose a threat to established payment players like Visa, especially with new legislation supporting digital asset infrastructure [6] - Visa's stablecoin strategy is viewed as more sophisticated compared to competitors like Mastercard, focusing on comprehensive infrastructure and settlement solutions [7]

·金价或继续受益于美元走弱 ·穆迪：澳大利亚2025年12月消费者通胀有望放缓 ·无头条催化下的避险潮凸显市场深层避险需求 ·摩根士丹利：英国受AI影响最深岗位流失速度达国际平均水平两倍 ·大和证券：日元若跌破159关口可能触发干预 ·瑞联银行：联合干预预期将削弱日元空头吸引力 ·瑞穗：日本最新汇率干预措施或更具效力 ·大和证券分析师木内英二表示，若美元兑日元升破159关口，日本政府可能干预外汇市场以阻止日元快 速走弱。他补充称，下一个警戒线在164水平。投资者此前认为美国会反对汇率干预，因为任何买入日 元、卖出美元的操作都会在日本方面出售美债筹集资金时推高美国国债收益率。然而，两位知情人士透 露，纽约联邦储备银行代表美国财政部，向多家银行询问了将日元兑换成美元的成本。这一不寻常的举 动被市场参与者解读为美国容忍此类行动的信号。 【机构分析】 ·瑞讯银行分析师Ipek Ozkardeskay表示，投资者涌入贵金属是一个明确的信号，表明尽管上周美欧紧张 局势部分缓和，但风险偏好并未回归。白银和黄金创下新高，值得注意的是，这次对避险资产的追捧并 非由重大的地缘政治头条新闻引发。Ozkardeskay表示，除了美国 ...

Acquisition Details - Perimeter Solutions, Inc. has completed the acquisition of Medical Manufacturing Technologies LLC for approximately $685 million in cash, including certain tax benefits [1] - The acquisition was financed using cash on hand and proceeds from a senior secured notes offering that closed on January 2, 2026 [1] Company Overview - Perimeter Solutions is a leading global solutions provider for the Fire Safety and Specialty Products industries, organized into two reporting segments: Fire Safety and Specialty Products [4] Fire Safety Segment - The Fire Safety segment formulates and manufactures fire management products to combat various types of fires, including wildland and structural fires [5] - This segment also offers specialized equipment and services to support firefighting operations, including mobile retardant bases and custom-designed equipment [5] - The service network can meet emergency resupply needs for approximately 150 air tanker bases in North America and other global locations [5] Specialty Products Segment - The Specialty Products segment develops and markets products for non-fire safety markets, including phosphorus derivatives and electronic components [6] - Phosphorus Pentasulfide produced by this segment is used in lubricant additives, pesticides, mining chemicals, and emerging electric battery technologies [6] - Intelligent Manufacturing Solutions within this segment focuses on a variety of product lines across communications, energy, defense, and industrial systems, with an emphasis on aftermarket repair and replacement [6] Medical Manufacturing Technologies (MMT) - MMT is a leading provider of highly engineered machinery and aftermarket consumables for minimally invasive medical devices, with nearly all revenue from proprietary products and about half from the aftermarket [2]

Core Viewpoint - The article discusses recent initiations of coverage by various financial institutions on several companies, highlighting their ratings and price targets, as well as the strategic insights behind these ratings. Group 1: Netflix (NFLX) - HSBC initiated coverage with a Buy rating and a price target of $107, citing Netflix's acquisitions as a response to challenges in a maturing video streaming industry, and labeling it the "undisputed global streaming leader" [1]. Group 2: Medline (MDLN) - Barclays initiated coverage with an Overweight rating and a price target of $50, emphasizing the company's scale, private-label differentiation, and logistics capabilities. Multiple firms including Wolfe Research, JPMorgan, and Goldman Sachs also started coverage with Buy-equivalent ratings, while Deutsche Bank and Wells Fargo initiated with Neutral-equivalent ratings [1]. Group 3: Andersen Group (ANDG) - Baird initiated coverage with an Outperform rating and a price target of $40, describing the company as a "highly differentiated premium provider" of tax, valuation, and advisory services. UBS and Deutsche Bank also initiated with Buy-equivalent ratings, while Morgan Stanley and Wells Fargo provided Neutral-equivalent ratings [1]. Group 4: Rocket Companies (RKT) - JPMorgan reinstated coverage with a Neutral rating and a price target of $24, expressing a constructive view on the company's new strategy but suggesting that investors may have already priced in lower rate scenarios and market share gains from acquisitions [1]. Group 5: Hims & Hers (HIMS) - Evercore ISI initiated coverage with an In Line rating and a price target of $33, viewing the current valuation as "reasonable" while noting that the market may be underestimating the durability and diversity of Hims' core platform [1].

Group 1 - William Blair downgraded Dynavax (DVAX) to Market Perform from Outperform following Sanofi's announcement to acquire the company for $15.50 per share [1] - The acquisition is viewed as logical due to increasing regulatory concerns around vaccines and investor inquiries regarding management's strategy for value creation [1] - Alliance Global downgraded Spire Global (SPIR) to Neutral from Buy, reducing the price target from $17 to $9, pending evidence of recovery [1] Group 2 - Spire Global's management anticipates achieving positive operating cash flow by Q4 of 2026, which requires a 15% increase in Q4 of 2025 revenue estimates and $36 million in annual expense reductions [1] - Alliance Global considers the required financial improvements for Spire Global as "unlikely" [1]

Group 1 - The core inflation in the U.S. dropped to a four-year low in November, but economists question the "authenticity" of the report due to significant data gaps caused by a record-length government shutdown [1] - The Consumer Price Index (CPI) report showed a year-over-year increase of 2.6% in November, the slowest growth since 2021, but the missing data from October led to assumptions that inflation did not occur that month [1][2] - Economists criticized the report's methodology, particularly the use of "carry-forward imputation" for housing prices, which assumed no price changes, leading to inconsistencies in the data [2][3] Group 2 - The largest discrepancies in the report were found in the housing category, which has been a major driver of inflation, with average rent increases of only 0.06% and owner-equivalent rent increases of 0.14% over two months [3] - Despite the anomalies, some economists believe inflation is cooling, although not to the extent suggested by the report, indicating a need for caution in interpreting the data [4]

Core Points - Kalaris Therapeutics, Inc. has entered into a securities purchase agreement for a private placement, aiming to raise approximately $50.0 million before expenses [1][3] - The private placement includes participation from both new and existing institutional investors [2] - Kalaris plans to use the net proceeds to fund the clinical development of TH103 for neovascular AMD and for general corporate purposes [4] Financial Details - The private placement involves the sale of 4,200,000 shares of common stock at $10.00 per share and pre-funded warrants for 800,000 shares at $9.9999 each [3] - The pricing of the securities reflects a premium over the closing price of Kalaris' common stock over the previous five trading days [3] - The transaction is expected to close on or about December 19, 2025, pending customary closing conditions [3] Company Background - Kalaris Therapeutics is focused on developing treatments for prevalent retinal diseases and was founded by Dr. Napoleone Ferrara, known for his work in anti-VEGF therapy [8]

Carvana Co. shares extended their rally to a record 12th straight session ahead of the online used-car dealer’s entry into the S&P 500 Index this month. The stock closed up 2.5% at an all-time high of $467.67 on Wednesday. The shares of Carvana, which went public in 2017, climbed over 50% from Nov. 21 close, the session before the run of gains began, and have added over $33 billion to the valuation over that stretch. Most Read from Bloomberg The strength follows strong third-quarter results, reported i ...